December 2024 Supplement - Endovascular Today
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Endovascular Today
The 2024 PAD Guideline Update: How It Affects Practice. The most significant changes from the previous guidelines, achieving buy-in and consensus, key trends, obstacles to achieving appropriate care, ensuring compliance with medical therapy and exercise, and effective communication and the multidisciplinary care team.
December 2024 Supplement - Endovascular Today
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.
Thoracic Aortic Aneurysms: At What Size Should We Intervene?
Thoracic aortic aneurysm (TAA) is a potentially life-threatening disorder that without intervention carries a poor prognosis. Once diagnosed, the 3-year survival for large degenerative TAAs (> 60 mm in diameter) is approximately 20%. 1 Hospital admissions in the United Kingdom for TAAs have doubled in the last decade, and von Allmen and colleagues reported a TAA hospital …
Merit Medical’s Wrapsody Receives FDA Approval
December 20, 2024—Merit Medical Systems, Inc. announced that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the FDA.
Iliac Vein Stenting: Best Practices for Patient Safety and Successful ...
Appropriate confirmatory diagnostic imaging on an “intent-to-treat” basis prior to stenting is critical. A combination of multiplanar venography and intravascular ultrasound (IVUS) are gold standards for proper stent placement to identify the degree of stenosis and length of disease.
Gore’s Excluder TAMBE Approved by FDA to Treat Complex Aortic …
January 25, 2024—Gore & Associates announced FDA approval for the Excluder thoracoabdominal branch endoprosthesis (TAMBE). The device is an off-the-shelf endovascular solution for the treatment of complex aneurysmal disease involving the visceral aorta.
January 2025 Issue - Endovascular Today
Deep Venous Disease Patient Advocacy. Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE survivor, about patient and physician engagement in the organization, educational and outreach initiatives in deep vein thrombosis/pulmonary embolism, how physicians can get involved in patient advocacy, and more.
Prostate Artery Embolization Shown to be Effective as a Long …
March 1, 2023—The Society of Interventional Radiology (SIR) announced findings from a new study that demonstrated that prostate artery embolization (PAE) provides long-term effectiveness in treating urinary symptoms caused by benign prostate hyperplasia (BPH).
Xeltis Receives FDA Breakthrough Device Designation for aXess …
November 19, 2024—Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular access conduit and that the first patient was enrolled in the aXess staged pivotal trial in the United States.. The aXess device is intended to enable the creation of a new, permanent, living vessel for hemodialysis vascular access, …